| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |